Astrazeneca (AZN) Net Income - Minority (2009)

Astrazeneca (AZN) recorded quarterly Net Income - Minority of -$2.0 million in Q4 2009.

Astrazeneca (AZN) Net Income - Minority (2009) Analysis & Trends

Astrazeneca's Net Income - Minority history runs 1 years deep, the most recent figure standing at -$2.0 million for Q4 2009.

In Q4 2009, Net Income - Minority changed N/A year-over-year to -$2.0 million; the TTM figure through Dec 2009 stood at -$2.0 million (changed N/A YoY), while the FY2009 annual figure was -$2.0 million, changed N/A from the prior year.
Net Income - Minority was -$2.0 million for Q4 2009 at Astrazeneca.
In the past five years, Net Income - Minority ranged from a high of -$2.0 million in Q4 2009 to a low of -$2.0 million in Q4 2009.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income - Minority (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	-
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	-
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	-
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	-
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	-
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	-
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	-
10	Astrazeneca	72.15 Bn	64.21 Bn	12.61 Bn	-

Historic Data

Download Data

Date	Value
Dec 31, 2009	-2.00 Mn